Aspirin neuroprotective in elderly women at high CV risk

An observational study of nearly 700 Swedish women aged 70 to 90 years, most of whom had a 10% or higher 10-year Framingham CV risk score, suggested aspirin may damp down inflammation and arrest cognitive decline by enhancing cerebral blood flow through its antiplatelet effects, researchers said.